2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or …
In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …
Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary—a …
GYH Lip, K Huber, F Andreotti, H Arnesen… - European heart …, 2010 - academic.oup.com
There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of …
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention …
GYH Lip, K Huber, F Andreotti… - Thrombosis and …, 2010 - thieme-connect.com
There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a North American perspective—2016 update
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation is an emerging clinical problem …
percutaneous coronary intervention with stent implantation is an emerging clinical problem …
Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis
Importance Antithrombotic treatment in patients with atrial fibrillation (AF) and percutaneous
coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic …
coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic …
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing …
Background: The safety and efficacy of antithrombotic regimens may differ between patients
with atrial fibrillation who have acute coronary syndromes (ACS), treated medically or with …
with atrial fibrillation who have acute coronary syndromes (ACS), treated medically or with …
Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation represents a challenge in clinical …
percutaneous coronary intervention with stent implantation represents a challenge in clinical …
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary …
D Capodanno, DJ Angiolillo - Circulation: Cardiovascular …, 2014 - Am Heart Assoc
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the risk for stroke
by≈ 65% and by≈ 20%, respectively. 17 However, oral antiplatelet agents do not perform …
by≈ 65% and by≈ 20%, respectively. 17 However, oral antiplatelet agents do not perform …
相关搜索
- atrial fibrillation antithrombotic therapy
- atrial fibrillation meta analysis
- atrial fibrillation management of antiplatelet
- anticoagulant therapy management of antiplatelet
- oral anticoagulation antithrombotic therapy
- atrial fibrillation oral anticoagulation
- atrial fibrillation safety and efficacy
- fibrillation patients antithrombotic therapy
- atrial fibrillation antithrombotic strategies
- atrial fibrillation anticoagulant therapy